Second-line treatment in exon 11-mutated GIST patients: Imatinib dose escalation or sunitinib? Retrospective analysis of a multi-institutional experience.
Bruno Vincenzi
No relevant relationships to disclose
Margherita Nannini
No relevant relationships to disclose
Elena Fumagalli
No relevant relationships to disclose
Giuseppina Maltese
No relevant relationships to disclose
Anna Maria Frezza
No relevant relationships to disclose
Daniele Santini
No relevant relationships to disclose
Mariella Spalato Ceruso
No relevant relationships to disclose
Giuseppe Badalamenti
No relevant relationships to disclose
Maria A. Pantaleo
No relevant relationships to disclose
Paolo Giovanni Casali
No relevant relationships to disclose
Giuseppe Tonini
No relevant relationships to disclose